AGP Executive Report
Last update: 14 minutes agoCannabinoid Industry: Brains Bioceutical agreed to a proposed $750 million SPAC merger and Nasdaq listing, aiming to expand pharmaceutical manufacturing and drug development, including CBD ingredients. Medical Products: MediPharm Labs reached a European regulatory milestone supporting commercialization of its metered-dose cannabis inhaler platform. Health Research: A study of nearly 450,000 U.S. adults linked cannabis use—even occasional use—to higher odds of cardiovascular disease and stroke; the findings are observational, not proof of cause. U.S. Policy: Federal registrations for more than 900 state-licensed medical cannabis dispensaries could ease a key business constraint as operators navigate new compliance rules. Cannabis History: Researchers found the oldest directly dated evidence of intoxicating cannabis use, in an 2,800-year-old Siberian tomb.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.